SENS logo

SENS
Senseonics Holdings Inc

48,705
Mkt Cap
$292.55M
Volume
2,756.00
52W High
$28.00
52W Low
$5.25
PE Ratio
-4.19
SENS Fundamentals
Price
$7.22
Prev Close
$7.16
Open
$7.21
50D MA
$6.32
Beta
1.75
Avg. Volume
432,142.86
EPS (Annual)
-$2.50
P/B
3.74
Rev/Employee
$192,068.38
News
all
press releases
SENS Stock Up as Eversense 365 Enters AID Market With twiist System
Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.
Zacks·6d ago
News Placeholder
More News
News Placeholder
SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System
Senseonics announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.
Stocktwits·7d ago
News Placeholder
Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Analysts
Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities...
MarketBeat·16d ago
News Placeholder
Maven Securities LTD Takes Position in Senseonics Holdings, Inc. $SENS
Maven Securities LTD acquired a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·1mo ago
News Placeholder
Hood River Capital Management LLC Invests $3.78 Million in Senseonics Holdings, Inc. $SENS
Hood River Capital Management LLC acquired a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the second quarter, according to the company in its most recent...
MarketBeat·1mo ago
News Placeholder
Vistagen Appoints Nick Tressler as Chief Financial Officer
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product...
Business Wire·2mo ago
News Placeholder
Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of -30.30% and +1.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3
Clover Health Investments (CLOV) delivered earnings and revenue surprises of -100.00% and +4.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
<
1
2
...
>

Latest SENS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.